Table 2 Adverse events
From: Activity of PD1 inhibitor therapy in advanced sarcoma: a single-center retrospective analysis
|  | Grade 1–2 | Grade 3 | Grade 4 | Grade 5 | Ungraded |
|---|---|---|---|---|---|
Fatigue | 31 (55.4%) | 5 (8.9%) | – | – | 1 (1.8%) |
Colitis | 2 (3.6%) | 1 (1.8%) | – | – | – |
Transaminitis | 2 (3.6%) | 1 (1.8%) | – | – | – |
Hypothyroidism | 2 (3.6%) | – | – | – | – |
AIHA | – | – | – | 1 (1.8%) | – |
Hypocalcemia | – | 1 (1.8%) | – | – | – |
Hyponatremia | – | 1 (1.8%) | – | – | – |
Pancreatitis | – | 1 (1.8%) | – | – | – |
Rash | – | 1 (1.8%) | – | – | – |
Endocarditis | 1 (1.8%) | – | – | – | – |
Pleural effusion | 1 (1.8%) | – | – | – | – |
Pneumonitis | 1 (1.8%) | 1 (1.8%) | – | – | – |
Uveitis | 1 (1.8%) | – | – | – | – |
Enteritis | – | – | – | – | 1 (1.8%) |
Psoriasis | – | – | – | – | 1 (1.8%) |